In collaboration with
Keyzell is a deeptech company specializing in artificial intelligence applied to healthcare. With an innovative approach, it develops big data and AI solutions to drive more personalized, efficient, and sustainable medicine.
Keyzell provides advanced oncology solutions using next-generation AI: with PAHO (Oncology Precision System) personalizes treatments by analyzing clinical and molecular data with 89% accuracy, and with SDGs (Oncology Diagnostic System) accelerates diagnoses thanks to deep learning, reducing times by up to 60%.
Scientific evidence in clinical decisions
Evidence-based clinical decision-making refers to the use of proven data and rigorous methodologies to guide medical practice, ranging from the use of manuals to clinical guidelines based on systematic research.
In this context, artificial intelligence should be seen not only as an additional technological tool, but as a comprehensive facilitator that enhances and expands the physician's diagnostic and therapeutic capabilities.
Its development and implementation should be careful and deliberate processes, fostering a cultural change that integrates human intelligence with advanced computational capabilities.
Ideally, artificial intelligence should complement medical intuition and experience, intervening in those cases—which constitute approximately 30%—where a deeper and more precise analysis is required.
This would allow artificial intelligence not only to support, but also to enrich clinical judgment by offering perspectives and analyses that go beyond human limitations, thus contributing to a more effective and patient-centered medical practice.o.
